Brain natriuretic peptide: potential adjunct for cardiac risk assessment and management during treatment with experimental anticancer agents.
Varterasian
Mary L
ML
Pfizer Global Research and Development, Ann Arbor, MI, USA.
Meyer
Mark B
MB
Pressler
Milton L
ML
Fingert
Howard J
HJ
LoRusso
Patricia M
PM
D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000009:adverse effects*; D015415:Biomarkers / Q000097:blood; D015507:Drugs, Investigational / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008875:Middle Aged; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D018570:Risk Assessment; D018487:Ventricular Dysfunction, Left / Q000097:blood / Q000139:chemically induced / Q000175:diagnosis
D000970:Antineoplastic Agents; D015415:Biomarkers; D015507:Drugs, Investigational; D020097:Natriuretic Peptide, Brain